About this event

  • Date and time Mon 6 Jul 2020 from 10:00am to 3:30pm
  • Location Royal Society of Medicine
  • Organised by Medicine and Me

**This event is sold out but you can still book the live stream!**

Please note: This event has been postponed and is now planned to take place in 2021. This page will be updated as soon as we have more details, and we will also contact booked delegates directly with this information. We apologise for any inconvenience this may have caused.

Jointly organised with Action for Pulmonary Fibrosis, this meeting will give you an understanding of what it is like to live with Idiopathic Pulmonary Fibrosis (IPF) from people living with the disease.

Pulmonary fibrosis (PF) is thought to affect around 70,000 people in the UK. One of the most aggressive and common forms of PF is Idiopathic Pulmonary Fibrosis (IPF). Idiopathic means it has no known cause. IPF normally affects people over 50 and is slightly more common in men than women. There are limited treatments and there is no cure. Life expectancy can be between three to five years following diagnosis, and around 6,000 people die from it every year in the UK.

Learn more about current approaches to diagnosis, treatment and management of IPF from the perspective of patients, their carers and clinicians, as well as gaining an insight into the psychological and emotional wellbeing of those living with IPF. We'll also explore the cutting edge research into improving outcomes and palliation, as we consider areas of inquiry likely to deliver step changes in treatments. 

 

What will you learn?

By attending this meeting, you will have the opportunity to:

  • Understand the most effective approaches to the diagnosis of IPF and the contribution of high-resolution imaging
  • Know about the pharmacology and use of current anti-fibrotic drugs and the underlying biology that may lead to new approaches to treatments
  • Understand the development of biomarkers, breath markers and other approaches to determining who is likely to respond to treatments
  • Know from patients’ perspectives about the importance of palliative options and support for symptoms including breathlessness and mental health concerns
  • Consider inequalities in access to management options, for example, care by specialist nurses
  • Consider likely avenues for ”step changes” in treating IPF

You can book a place to join the live stream here

 

About Medicine and Me

Medicine and Me meetings aim to provide an outline of current best practice and future updates of important conditions and to give direct voice to patients and their carers and enable them to discuss their concerns and reflections on the impact of diagnosis, investigation and management. Physicians and surgeons and indeed all healthcare professionals continue to learn from and be inspired to greater efforts to improve care by hearing directly from patients.

Join in the conversation online
Follow us on Twitter: @RoySocMed

 

We would like to thank our sponsors(s):

Galecto Biotech AB

Please note that none of the companies listed have had any influence or involvement over the agenda, content or organisation of this meeting.

Tickets

Early Bird pricing available until 06 June 2020.

Member

RSM Fellow RSM Associate RSM Retired Fellow RSM Student RSM Trainee
£36.00 £18.00 £15.00 £0.00 £0.00

Non - Member

Consultant / GP AHP / Nurse / Midwife Student Trainee Patient / Carer / Relative
£60.00 £30.00 £0.00 £0.00 £0.00

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction

Dr Fiona Moss, Dean, Royal Society of Medicine

Introduction to the day

Mr Steve Jones, Chair, Action for Pulmonary Fibrosis

Living with Idiopathic Pulmonary Fibrosis – patients’ perspectives

Diagnostic journeys - Mr Howard Almond, Company Director, IP Import Limited

Anti-fibrotic drugs and daily life - Mr Ronald Fish, Secretary, Papworth Hospital Pulmonary Fibrosis Support Group

Idiopathic Pulmonary Fibrosis: what is it, who gets it and why?

Dr Simon Hart, Reader in Respiratory Medicine, Castle Hill Hospital

Speeding up the diagnostic journey: Step changes in diagnosis

Dr Simon Walsh, Consultant Thoracic Radiologist and National Institute for Health Research Clinician Scientist, National Heart and Lung Institute, Imperial College, London and Dr Simon Hart

Panel discussion

Dr Simon Hart, Dr Simon Walsh and patients

Lunch
Current and future treatments for Idiopathic Pulmonary Fibrosis

Dr Helen Parfrey, Consultant Respiratory Physician, Royal Papworth Hospital

Discussion with Dr Helen Parfrey
Life with Pulmonary Fibrosis: What helps?

Ms Maxine Flewett, Papworth Hospital Pulmonary Fibrosis Support Group, Carer

Dr Melissa Wickremasinghe, Consultant Respiratory Physician, St Mary’s Hospital, Imperial College Healthcare NHS Trust

Dr Anne-Marie Russell, Senior Clinical Research Fellow and Honorary Idiopathic Pulmonary Fibrosis Nurse Consultant, Imperial College Healthcare NHS Trust

Panel discussion

Ms Maxine Flewett, Dr Anne-Marie Russell and Dr Melissa Wickremasinghe

Panel discussion: Looking forwards together: Step changes in treatments, what are the priorities?

Dr Helen Parfrey, Dr Simon Hart, Dr Melissa Wickremasinghe, Dr Helen Parfrey, Dr Anne-Marie Russell and patients

Closing comments

Mr Steve Jones

Close of meeting, tea and coffee

Sponsors

Galecto Biotech AB

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 7 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 

 

Become a member